Skip to main content
OpenTrials
Completed

NCT Number: NCT00465803

A Phase IIIb Study of DuoTrav to Treat Glaucoma or Ocular Hypertension

The purpose of this study is to assess patient compliance with DuoTrav versus concomitant administration of Timolol 0.5% plus TRAVATAN in patients with open-angle glaucoma or ocular hypertension.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Open-angle Glaucoma Eye Diseases Glaucoma Glaucoma, Open-Angle Ocular Hypertension

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

Seattle

Seattle, Washington, 98104, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult patients with open-angle glaucoma or ocular hypertension;
  • Other protocol-defined inclusion criteria may apply.

Exclusion criteria

  • Visual acuity worse than 0.60;
  • Other protocol-defined exclusion criteria may apply.

Treatment and study plan

Travoprost 0.004%/Timolol 0.5% Ophthalmic Solution

Drug

One drop in the study eye(s) once daily at either 8 AM or 8 PM for twelve months using the Dosing Aid

Other names: DuoTrav

Travoprost ophthalmic solution, 0.004%

Drug

One drop in the study eye(s) once daily at 8 PM for twelve months using the Dosing Aid

Other names: TRAVATAN

Timolol Maleate Ophthalmic Solution, 0.5%

Drug

One drop in the study eye(s) once daily at 8 AM or twelve months using the Dosing Aid

Primary outcomes

  1. Patient compliance

    Time frame: 12 months

    Patient compliance will be measured with a dosing aid that records time and date of study drug administration

Sponsors and collaborators

Lead sponsor

Alcon Research

Industry

Registry information

Official study title

Compliance Study Comparing DuoTrav to TRAVATAN Plus Timolol Using the Dosing Aid

Important dates

Study start
2007
Primary completion
2009
First posted
Apr 25, 2007
Registry last updated
Jul 24, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.